Business Context and Reporting Period
This Form 8-K filing by DarioHealth Corp. (an emerging growth company) was submitted on October 17, 2018, reporting events that occurred on October 15 and October 16, 2018. The filing addresses changes to the composition of the Company's Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignations: On October 15, 2018, Ori Zanco and Rami Yehudiha voluntarily resigned from their positions as members of the Board of Directors. The Company stated that neither resignation resulted from any disagreement with the Company regarding operations, policies, or practices.
- Appointment: On October 16, 2018, Glen Moller was appointed to the Board of Directors to fill the vacancy created by Mr. Zanco's resignation. The appointment took effect immediately.
Management Commentary and Background
The filing provides a detailed professional background for the new appointee, Glen Moller, highlighting a 25-year career in healthcare and technology. Key aspects of his experience include:
- Operating Partner at Frazier Healthcare Partners (since April 2018).
- Former CEO and Director of ArroHealth, Inc. (2011–2017), focusing on population health analytics.
- Former interim CEO of Centene Corporation (2010–2011).
- Former President of Fidelis SecureCare (2008–2010) and COO of Express Scripts Insurance Company.
- Education: B.A. from Boston College and M.B.A. from Harvard Business School.
The Company confirmed there are no undisclosed arrangements or transactions involving Mr. Moller requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective date of Glen Moller's board appointment (October 16, 2018).
- Confirm the voluntary nature of the resignations by Ori Zanco and Rami Yehudiha and the absence of disputes.
- Review Mr. Moller's specific expertise in managed care and technology-enabled health services to assess strategic alignment.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.